Global Injection Pen Market is valued USD 33.0 billion in 2017 is anticipated to grow USD 68.0 billion with the compounded annual growth of 9.5% over the forecast period 2018-2025.
New York 16 Aug 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Injection Pen market industry is poised to raise USD 68.0 billion by 2025. The market is driven by increasing application of injectable pens in various fields such as diabetes, anaphylaxis, osteoporosis, growth hormone deficiency, and arthritis. The injectable pen aids to prevention, treatment, and management of various diseases. The convenience & ease of usage of Injection Pen is the driver factors in this market. The biotechnology and pharmaceutical industries is adopting the modern method of inserting drugs. Significant efforts from the major market players in terms of product innovation and increasing R&D investments are creating new opportunities in the market over the forecast period. These efforts are primarily targeted towards the end user ease such as less maintenance, higher volume, and thinner needles. The injectable pens and drug delivery pumps comes with a feature of loading cartridges & needles from time to time which is different from traditional method and it’s result to a higher demand of .
To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global Injection Pen Market Size study, by Product (Disposable, Reusable, Others), by Application (Diabetes, Insulin, Non-Insulin, Anaphylaxis, Osteoporosis, Growth hormone deficiency, Arthritis), and by Regional Forecasts 2018-2025
The industry is seeming to be fairly competitive. Some of the leading market players include Owen Mumford Ltd, Eli Lilly And Company, GlaxoSmithKline plc, Mylan N.V., Astra Zeneca, Novo Nordisk A/S, Novartis AG, Sanofi and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- Among the various applications diabetes accounts for the largest share in the market share in 2017.
- The North America contributes to the largest share in the global market & is growing at a lucrative CAGR of XX% over the forecast period.
Bizwit Research & Consulting LLP has considered following segments for the study:
- Growth hormone deficiency
- North America
- Asia Pacific
- Latin America
- Rest of the World